Skip to main content

Table 5 Univariate and multivariate analysis for patient with intermediate-risk factors

From: The feasibility of 18F-FDG PET/CT for predicting pathologic risk status in early-stage uterine cervical squamous cancer

Variable

Intermediate-risk (No. %)

Univariate

Multivariate

No

Yes

p value

OR

95% CI

p value

Age (year)

  

0.139

   

 < 50.5

22 (9.5%)

119 (51.5%)

    

 ≥ 50.5

8 (3.5%)

82 (35.5%)

    

SCCA (ng/ml)

  

< 0.001

6.099

1.640–22.683

0.007

 < 2.45

27 (12.1%)

81 (36.2%)

    

 ≥ 2.45

3 (1.3%)

113 (50.4%)

    

FIGO stage

  

< 0.001

–

–

0.087

 IA2-IB2

21 (9.1%)

72 (31.2%)

    

 IIA1-IIA2

9 (3.9%)

129 (55.8%)

    

SUVmax

  

< 0.001

2.821

1.087–7.323

0.033

 < 7.96

16 (7.0%)

28 (12.2%)

    

 ≥ 7.96

13 (5.7%)

173 (75.2%)

    

MTV

  

< 0.001

–

–

0.384

 < 20.88

24 (10.5%)

49 (21.4%)

    

 ≥ 20.88

5 (2.2%)

151 (65.9%)

    

TLG

  

< 0.001

8.643

1.770–42.196

0.008

 < 137.40

27 (11.8%)

69 (30.1%)

    

 ≥ 137.40

2 (0.9%)

131 (57.2%)

    
  1. Abbreviation: SCCCA Squamous cell carcinoma associated antigen, SUVmax maximum of standardized uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us